NDC 63629-6871

Topiramate

Topiramate

Topiramate is a Oral Capsule, Coated Pellets in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Topiramate.

Product ID63629-6871_207666fe-4aed-4c23-9467-982c0997af3d
NDC63629-6871
Product TypeHuman Prescription Drug
Proprietary NameTopiramate
Generic NameTopiramate
Dosage FormCapsule, Coated Pellets
Route of AdministrationORAL
Marketing Start Date2009-04-17
Marketing CategoryANDA / ANDA
Application NumberANDA076575
Labeler NameBryant Ranch Prepack
Substance NameTOPIRAMATE
Active Ingredient Strength15 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 63629-6871-1

30 CAPSULE, COATED PELLETS in 1 BOTTLE (63629-6871-1)
Marketing Start Date2015-12-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-6871-2 [63629687102]

Topiramate CAPSULE, COATED PELLETS
Marketing CategoryANDA
Application NumberANDA076575
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-12-22
Inactivation Date2020-01-31

NDC 63629-6871-1 [63629687101]

Topiramate CAPSULE, COATED PELLETS
Marketing CategoryANDA
Application NumberANDA076575
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-12-22
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
TOPIRAMATE15 mg/1

OpenFDA Data

SPL SET ID:cc1d0a52-17eb-4934-b283-6fac3057e955
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 205316

    • Pharmacological Class

    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Cytochrome P450 3A4 Inducers [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]

    NDC Crossover Matching brand name "Topiramate" or generic name "Topiramate"

    NDCBrand NameGeneric Name
    0093-7335TopiramateTopiramate
    0093-7336TopiramateTopiramate
    0615-7562TopiramateTopiramate
    0615-7563TopiramateTopiramate
    0615-7564TopiramateTopiramate
    0615-7565TopiramateTopiramate
    0615-8138TopiramateTopiramate
    0615-8139TopiramateTopiramate
    68071-3012TopiramateTopiramate
    68071-3088TopiramateTopiramate
    68071-3196TopiramateTopiramate
    68071-1960TopiramateTopiramate
    68071-1971TopiramateTopiramate
    68071-1900TopiramateTopiramate
    68071-4793topiramatetopiramate
    68071-4760topiramatetopiramate
    68084-344TopiramateTopiramate
    68084-342TopiramateTopiramate
    68071-4756topiramatetopiramate
    68084-345TopiramateTopiramate
    68258-7159TOPIRAMATETOPIRAMATE
    68382-138topiramatetopiramate
    68382-004topiramatetopiramate
    68258-3000TOPIRAMATETOPIRAMATE
    68258-3002TOPIRAMATETOPIRAMATE
    68258-3001TOPIRAMATETOPIRAMATE
    68382-139topiramatetopiramate
    68258-7056TOPIRAMATETOPIRAMATE
    68382-140topiramatetopiramate
    68382-005topiramatetopiramate
    68258-7156TOPIRAMATETOPIRAMATE
    68382-141topiramatetopiramate
    68382-769TopiramateTopiramate
    68382-864TopiramateTopiramate
    68387-559TopiramateTopiramate
    68387-558TopiramateTopiramate
    68387-560TopiramateTopiramate
    68382-863TopiramateTopiramate
    68462-109TopiramateTopiramate
    68462-110TopiramateTopiramate
    68462-108TopiramateTopiramate
    68462-153TopiramateTopiramate
    68788-6435TopiramateTopiramate
    68788-7016TopiramateTopiramate
    68788-6377TopiramateTopiramate
    68788-6770TopiramateTopiramate
    68788-7351topiramatetopiramate
    68788-8965TopiramateTopiramate
    68788-6366TopiramateTopiramate
    68788-6916TopiramateTopiramate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.